Treatment of: hypersalivation in adults and children (non-Parkinson’s disease)
Oral glycopyrronium bromide is recommended in adults and children with neurological conditions and hypersalivation following assessment by a specialist experienced in the treatment of patients with neurological conditions.
The long-term safety of oral glycopyrronium has not been confirmed therefore treatment is recommended for short-term intermittent use with frequent reviews of efficacy and adverse effects.
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist